Long-term Outcomes of Drug-eluting Stents in Symptomatic Intracranial Stenosis.
10.5469/neuroint.2013.8.1.9
- Author:
Soonchan PARK
1
;
Dong Geun LEE
;
Won Jung CHUNG
;
Deok Hee LEE
;
Dae Chul SUH
Author Information
1. Departments of Radiology and Research Institute of Radiology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. dcsuh@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Drug-eluting stents;
Intracranial stenosis;
Atherosclerosis
- MeSH:
Angiography;
Atherosclerosis;
Basilar Artery;
Caves;
Cerebral Arteries;
Constriction, Pathologic;
Drug-Eluting Stents;
Follow-Up Studies;
Heart;
Humans;
Middle Cerebral Artery;
Stents;
Thrombosis;
Vertebral Artery
- From:Neurointervention
2013;8(1):9-14
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The use of drug-eluting stent (DES) to treat intracranial stenosis has shown short-term success. However, there are no reports regarding the long-term results of DES. We present the long-term clinical outcome after DES stenting for symptomatic severe intracranial stenosis. MATERIALS AND METHODS: Our study included a consecutive series of 11 patients who underwent intracranial stenting using DES between March and July, 2006, during the time when bare metal stents were not available at our medical institution. The mean patient age was 59 years. Lesion location was the middle cerebral artery in five patients, the intradural vertebral artery in three, the basilar artery in one, the vertebrobasilar junction in one, and the cavernous internal cerebral artery in one patient. We evaluated the technical success, defined as reduction of residual stenosis < or =30% in the target lesion) as well as the clinical and imaging outcomes as long as 75 months following the procedure. In addition to a cerebral angiogram (n = 2), follow-up study was obtained by CT angiography (n = 6) or intracranial Doppler imaging (n = 2) during a mean time of 55 months after the procedure (range, 24 to 73 months). Three patients refused imaging follow-up and accepted only clinical follow-up. The mean clinical follow-up period was 67 months (range, 47-75 months). RESULTS: Stenting in all patients was technically successful and without periprocedural complications. There was thrombus formation during the procedure in one patient who experienced no further complications. There were no new neurological events during the mean follow-up period of 5.6 years. No patients were found to have restenosis > or =50% at during the mean follow-up period of 55 months. One patient died of a sudden heart attack 59 months following the procedure which was regarded as unrelated to the cerebral lesion. CONCLUSION: Our study demonstrates that DES shows long-term stability and safety, and results in good clinical outcomes with a low rate of restenosis.
